Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUIXIL Validation in Hip Replacement
2008-002024-28Phase 4Completed
- Sponsor
- Policlinico San Donato
- Start
- Apr 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of quixil in hip osteoarthritis and Hypertrophic osteoarthropathy (HOA), sponsored by Policlinico San Donato. Primary endpoint: Quantity of transfused blood. Started Apr 2008; status: completed.
02
Drugs
quixil
03
Conditions
hip osteoarthritisHypertrophic osteoarthropathy (HOA)
Beyond the preview
Go deeper on 2008-002024-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002024-28.